This section presents pharmaceutical projects that are announced from time-to-time around the world.
LFB Biomanufacturing is planning a capacity expansion of its industrial site in France, Europe The expansion will not only boost production capabilities
Thermo Fisher Scientific is investing $58 million to expand its GMP lab in Wisconsin, USA This new stateoftheart facility spans 72,500 square feet and includes a clinical research laboratory building
Sanofi is investing US$375 million 35 million to open new bioproduction capacity at its facilities in VitrysurSeine Val dae Marne, Loe Trait SeineMaritime, and Lyon Gerland Rhne in France
Kyowa Kirin invests US$530 million to construct a stateoftheart manufacturing facility in North Carolina, USA The 171,700squarefoot, tworeactor facility will accelerate the development
Aurigene Pharmaceutical Services is set to open a new biologics facility in India, providing process development and clinicalscale manufacturing capabilities
Kymanox is planning to expand its device design and testing facility, significantly enhancing its laboratory testing capabilities and increasing its CGxP footprint in the USA
Integrated DNA Technologies plans to open new stateoftheart synthetic biology hub in Lowa, USA This expansion marks a significant enhancement of its synthetic biology
Eli Lilly invests US$9 million in the newest Indiana site to boost API production for tirzepatide and pipeline medicines in USA This expansion will increase the capacity to manufacture active pharmaceutical ingredients
Akoya Biosciences is planning to launch its stateoftheart operations and manufacturing centre of excellence in Massachusetts, USA The newly established operations and manufacturing
AstraZeneca is set to invest US$15 billion to open a new manufacturing facility for antibody drug conjugates in Singapore This stateoftheart greenfield facility
